Clinical Trial

A Study of Single Dose of BL0175 in Postmenopausal Women

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 26, 2026 (before its estimated May 8, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn the safety and PK of the single dose of BL0175 Injection in postmenopausal women and to compare that with a single dose of Fulvestrant Injection. The main questions it aims to answer are: * What medical problems do participants have when using drug BL0175? * How long can BL0175 remain in your blood? Participants will receive a single dose of drug BL0175 or a single dose of Fulvestrant Injection in a randomized method
Trial Details
NCT Number NCT07366632
Lead Sponsor Shanghai Best-Link Bioscience, LLC
Conditions Postmenopausal Women
Enrollment 27 participants
Start Date 2026-01-26
Primary Completion 2026-05-08 (estimated)
Study Completion 2026-12-21 (estimated)
Updated on ClinicalTrials.gov 2026-01-26